Fierce Pharma: GLP-1 surge, oncology stars to power industry’s earnings growth over the next 18 months: Moody’s
![](https://b3252753.smushcdn.com/3252753/wp-content/uploads/2022/11/healthcare.jpg?lossy=2&strip=1&webp=1)
For more information about our integrated research solutions and how Third Bridge can help you make smarter and faster investment decisions, please contact us.